Literature DB >> 18192273

Functional mitochondria are required for alpha-synuclein toxicity in aging yeast.

Sabrina Büttner1, Alessandro Bitto, Julia Ring, Manuela Augsten, Piotr Zabrocki, Tobias Eisenberg, Helmut Jungwirth, Sylvia Hutter, Didac Carmona-Gutierrez, Guido Kroemer, Joris Winderickx, Frank Madeo.   

Abstract

alpha-Synuclein is one of the principal toxic triggers of Parkinson disease, an age-associated neurodegeneration. Using old yeast as a model of alpha-synuclein expression in post-mitotic cells, we show that alpha-synuclein toxicity depends on chronological aging and results in apoptosis as well as necrosis. Neither disruption of key components of the unfolded protein response nor deletion of proapoptotic key players (including the yeast caspase YCA1, the apoptosis-inducing factor AIF1, or the serine protease OMI) did prevent alpha-synuclein-induced cell killing. However, abrogation of mitochondrial DNA (rho(0)) inhibited alpha-synuclein-induced reactive oxygen species formation and subsequent apoptotic cell death. Thus, introducing an aging yeast model of alpha-synuclein toxicity, we demonstrate a strict requirement of functional mitochondria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192273     DOI: 10.1074/jbc.M708477200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Triclabendazole protects yeast and mammalian cells from oxidative stress: identification of a potential neuroprotective compound.

Authors:  Yong Joo Lee; Elodie Burlet; Shaoxiao Wang; Baoshan Xu; Shile Huang; Floyd J Galiano; Stephan N Witt
Journal:  Biochem Biophys Res Commun       Date:  2011-09-16       Impact factor: 3.575

2.  Meclizine is neuroprotective in models of Huntington's disease.

Authors:  Vishal M Gohil; Nicolas Offner; James A Walker; Sunil A Sheth; Elisa Fossale; James F Gusella; Marcy E MacDonald; Christian Neri; Vamsi K Mootha
Journal:  Hum Mol Genet       Date:  2010-10-25       Impact factor: 6.150

3.  Endonuclease-G and the pathways to dopaminergic neurodegeneration: a question of location?

Authors:  Marion C Hogg; Jochen H M Prehn
Journal:  EMBO J       Date:  2013-10-25       Impact factor: 11.598

Review 4.  Aging and cell death in the other yeasts, Schizosaccharomyces pombe and Candida albicans.

Authors:  Su-Ju Lin; Nicanor Austriaco
Journal:  FEMS Yeast Res       Date:  2013-11-08       Impact factor: 2.796

5.  The migration of mitochondrial DNA fragments to the nucleus affects the chronological aging process of Saccharomyces cerevisiae.

Authors:  Xin Cheng; Andreas S Ivessa
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

6.  Autophagy proteins play cytoprotective and cytocidal roles in leucine starvation-induced cell death in Saccharomyces cerevisiae.

Authors:  Slawomir A Dziedzic; Allan B Caplan
Journal:  Autophagy       Date:  2012-02-24       Impact factor: 16.016

Review 7.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

8.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 9.  Apoptotic death of ageing yeast.

Authors:  Patrick Rockenfeller; Frank Madeo
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

10.  The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer.

Authors:  Christoph Ruckenstuhl; Sabrina Büttner; Didac Carmona-Gutierrez; Tobias Eisenberg; Guido Kroemer; Stephan J Sigrist; Kai-Uwe Fröhlich; Frank Madeo
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.